Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Raymed Labs Ltd
Your Vote -
Buy
50.00%
Hold
0.00%
Sell
50.00%
50.00%
2 users have voted
Option Chain
Analyzes market sentiment, predicts Raymed Labs Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Raymed Labs Limi - Disclosure On Related Party Transaction
-
Raymed Labs Limi - Financial Results For Financial Year Ended 31St March 2025
-
Raymed Labs Limi - Board Meeting Outcome for Board Meeting Outcome For Meeting Held On 22Nd May, 2025
-
Raymed Labs Limi - Board Meeting Intimation for Meeting Schedule On 22Nd May, 2025
-
Raymed Labs Limi - Intimation For Receipt Of Approval For Change In Main Object Of Company
-
Raymed Labs Limi - Announcement under Regulation 30 (LODR)-Change of Company Name
-
Raymed Labs Limi - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report
-
Raymed Labs Limi has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025
-
Raymed Labs Limi - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
-
Raymed Labs Limi - Shareholder Meeting / Postal Ballot-Outcome of EGM
-
Raymed Labs Limi - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Raymed Labs Limi - Intimation Of Notice Of Extra Ordinary General Meeting Of The Company.
-
Raymed Labs Limi - Appointment Of Internal Auditor
-
Raymed Labs Limi - Announcement under Regulation 30 (LODR)-Resignation of Director
-
Raymed Labs Limi - Appointment of Company Secretary and Compliance Officer
-
Raymed Labs Limi - Board Meeting Outcome for Meeting Held On 25Th March, 2025
Key fundamentals
Evaluate the intrinsic value of Raymed Labs Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | -0.2167 | -2.4075 | -2.3058 | -2.1349 | 0.1104 |
| Liabilities | -0.2167 | -2.4075 | -2.3058 | -2.1349 | 0.1104 |
| Equity | 4.2735 | 4.2735 | 4.2735 | 4.2735 | 4.2735 |
| Gross Profit | -0.5871 | -0.0968 | -0.1861 | -0.0768 | -0.0697 |
| Net Profit | -0.1805 | -0.1016 | -0.1709 | -0.082 | -0.0688 |
| Cash From Operating Activities | -0.5895 | -0.0606 | -0.1637 | -2.2065 | 0.0003 |
| NPM(%) | 0 | 0 | 0 | 0 | 0 |
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0.5871 | 0.0968 | 0.1861 | 0.0768 | 0.0697 |
| ROE(%) | 6.97 | 3.92 | 6.6 | 3.17 | 2.65 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Raymed Labs Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 859.90 | 1.12 | 28.38 | 1.89 | 301.39 | 0.58 |
| Lotus Eye Hospital and Institute Ltd | 72.27 | -2.54 | 205.89 | 6.90 | 3.55 | 0.00 |
| Bharat Immunological and Biologicals Corporation Ltd | 26.00 | 1.13 | 0.00 | 14.34 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 806.15 | -0.38 | 0.00 | 6.51 | -687.10 | 0.00 |
Company Info
Raymed Labs Ltd. was established in 1994 as a pharmaceutical company with emphasis on injectables with state of the art manufacturing facilities on Dehradun Road, Saharanpur, UP. Manufacturing pharmaceutical products, as such, is a specialized job, however, manufacturing of injectables is even more difficult since they are normally given during a life saving situation thus their quality standards are much more stringent. Raymed's quality quickly won the trusts of doctors and it established itself as one of the leading quality manufacturers of medicines in the area.
Raymed Labs Ltd. was established in 1994 as a pharmaceutical company with emphasis on injectables with state of the art manufacturing facilities on Dehradun Road, Saharanpur, UP. Manufacturing pharmaceutical products, as such, is a specialized job, however, manufacturing of injectables is even more difficult since they are normally given during a life saving situation thus their quality standards are much more stringent. Raymed's quality quickly won the trusts of doctors and it established itself as one of the leading quality manufacturers of medicines in the area.
Read More
Parent Organisation
Raymed Labs Ltd.
Founded
30/03/1992
Managing Director
NSE Symbol
FAQ
The current price of Raymed Labs Ltd is
The 52-week high for Raymed Labs Ltd is
The market capitalization of Raymed Labs Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Raymed Labs Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Raymed Labs Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Raymed Labs Ltd shares.
The CEO of Raymed Labs Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
